Measure and countermeasure: Type I IFN (IFN-α/β) antiviral response against West Nile virus

Journal of Innate Immunity

Volumn 1, Issue 5, 2009, Pages 435-445

  Daffis, Stephane ^a   Suthar, Mehul S ^b   Gale Jr , Michael ^b   Diamond, Michael S ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Infectious diseases; Innate immunity; Pathogen associated molecular patterns; Pattern recognition; Toll like receptor; Viral infection; Virus host cell interactions

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; INTERFERON REGULATORY FACTOR 3; INTERFERON REGULATORY FACTOR 7; PROTEIN KINASE R; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8;

CYTOKINE PRODUCTION; DENDRITIC CELL; FIBROBLAST; GENE INDUCTION; GENETIC TRANSCRIPTION; HOST; INNATE IMMUNITY; MACROPHAGE; MOLECULAR RECOGNITION; NERVE CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; VIRUS INDUCTION; VIRUS INFECTION; VIRUS REPLICATION; WEST NILE FLAVIVIRUS;

ANIMALS; ANTIVIRAL AGENTS; HUMANS; IMMUNITY, INNATE; INTERFERON-ALPHA; INTERFERON-BETA; MICE; PATTERN RECOGNITION, AUTOMATED; SIGNAL TRANSDUCTION; WEST NILE FEVER; WEST NILE VIRUS;

EID: 77953464434     PISSN: 1662811X     EISSN: 16628128     Source Type: Journal    
DOI: 10.1159/000226248     Document Type: Review

References (82)

1. Le Bon A, Tough DF: Type I interferon as a stimulus for cross-priming. Cytokine Growth Factor Rev 2008;19:33-40.
2. Theofilopoulos AN, Baccala R, Beutler B, Kono DH: Type I interferons (alpha/beta) in immunity and autoimmunity. Annu Rev Immunol 2005;23:307-336. (Pubitemid 40563172)
3. van Pesch V, Lanaya H, Renauld JC, Michiels T: Characterization of the murine alpha interferon gene family. J Virol 2004;78:8219-8228. (Pubitemid 38944305)
4. Pestka S, Krause CD, Walter MR: Interferons, interferon-like cytokines, and their receptors. Immunol Rev 2004;202:8-32. (Pubitemid 39576902)
5. Lenschow DJ, Lai C, Frias-Staheli N, Giannakopoulos NV, Lutz A, Wolff T, Osiak A, Levine B, Schmidt RE, Garcia-Sastre A, Leib DA, Pekosz A, Knobeloch KP, Horak I, Virgin HWt: IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and sindbis viruses. Proc Natl Acad Sci USA 2007;104:1371-1376. (Pubitemid 46184011)
6. Degols G, Eldin P, Mechti N: ISG20, an actor of the innate immune response. Biochimie 2007;89:831-835. (Pubitemid 47001639)
7. Zhang Y, Burke CW, Ryman KD, Klimstra WB: Identification and characterization of interferon-induced proteins that inhibit alphavirus replication. J Virol 2007;81:11246-11255. (Pubitemid 47536097)
8. Samuel MA, Whitby K, Keller BC, Marri A, Barchet W, Williams BR, Silverman RH, Gale M Jr, Diamond MS: PKR and RNAse l contribute to protection against lethal West Nile virus infection by controlling early viral spread in the periphery and replication in neurons. J Virol 2006;80:7009-7019. (Pubitemid 44025199)
9. Samuel MA, Diamond MS: Alpha/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival. J Virol 2005;79:13350-13361.
10. Anderson JF, Rahal JJ: Efficacy of interferon alpha-2b and ribavirin against West Nile virus in vitro. Emerg Infect Dis 2002;8:107-108.
11. Morrey JD, Day CW, Julander JG, Blatt LM, Smee DF, Sidwell RW: Effect of interferonalpha and interferon-inducers on West Nile virus in mouse and hamster animal models. Antivir Chem Chemother 2004;15:101-109.
12. Keller BC, Fredericksen BL, Samuel MA, Mock RE, Mason PW, Diamond MS, Gale M Jr: Resistance to alpha/beta interferon is a determinant of West Nile virus replication fitness and virulence. J Virol 2006;80:9424-9434.
13. Kumagai Y, Takeuchi O, Akira S: Pathogen recognition by innate receptors. J Infect Chemother 2008;14:86-92.
14. Takeuchi O, Akira S: Recognition of viruses by innate immunity. Immunol Rev 2007;220:214-224.
15. Takeuchi O, Akira S: MDA5/RIG-I and virus recognition. Curr Opin Immunol 2008;20:17-22.
16. Yoneyama M, Fujita T: RNA recognition and signal transduction by RIG-I-like receptors. Immunol Rev 2009;227:54-65.
17. Saito T, Hirai R, Loo YM, Owen D, Johnson CL, Sinha SC, Akira S, Fujita T, Gale M Jr: Regulation of innate antiviral defenses through a shared repressor domain in rig-i and lgp2. Proc Natl Acad Sci USA 2007;104:582-587. (Pubitemid 46123068)
18. Komuro A, Horvath CM: RNA- and virus-independent inhibition of antiviral signaling by RNA helicase LGP2. J Virol 2006;80:12332-12342. (Pubitemid 44904383)
19. Kato H, Takeuchi O, Mikamo-Satoh E, Hirai R, Kawai T, Matsushita K, Hiiragi A, Dermody TS, Fujita T, Akira S: Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J Exp Med 2008;205:1601-1610. (Pubitemid 351962024)
20. Saito T, Gale M Jr: Differential recognition of double-stranded RNA by RIG-I-like receptors in antiviral immunity. J Exp Med 2008;205:1523-1527. (Pubitemid 351962014)
21. Takahasi K, Yoneyama M, Nishihori T, Hirai R, Kumeta H, Narita R, Gale M Jr, Inagaki F, Fujita T: Nonself RNA-sensing mechanism of RIG-I helicase and activation of antiviral immune responses. Mol Cell 2008;29:428-440.
22. Saito T, Owen DM, Jiang F, Marcotrigiano J, Gale M Jr: Innate immunity induced by composition- dependent RIG-I recognition of hepatitis C virus RNA. Nature 2008;454:523-527.
23. Myong S, Cui S, Cornish PV, Kirchhofer A, Gack MU, Jung JU, Hopfner KP, Ha T: Cytosolic viral sensor RIG-I is a 5′-triphosphate-dependent translocase on double-stranded RNA. Science 2009;323:1070-1074.
24. Meylan E, Curran J, Hofmann K, Moradpour D, Binder M, Bartenschlager R, Tschopp J: Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 2005;437:1167-1172. (Pubitemid 41509355)
25. Kawai T, Takahashi K, Sato S, Coban C, Kumar H, Kato H, Ishii KJ, Takeuchi O, Akira S: IPS-1, an adaptor triggering RIG-I- and MDA5-mediated type I interferon induction. Nat Immunol 2005;6:981-988. (Pubitemid 41486182)
26. Seth RB, Sun L, Ea CK, Chen ZJ: Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 2005;122:669-682. (Pubitemid 41242633)
27. Sun Q, Sun L, Liu HH, Chen X, Seth RB, Forman J, Chen ZJ: The specific and essential role of MAVS in antiviral innate immune responses. Immunity 2006;24:633-642. (Pubitemid 43728147)
28. Kumar H, Kawai T, Kato H, Sato S, Takahashi K, Coban C, Yamamoto M, Uematsu S, Ishii KJ, Takeuchi O, Akira S: Essential role of IPS-1 in innate immune responses against RNA viruses. J Exp Med 2006;203:1795-1803. (Pubitemid 44036284)
29. Fredericksen BL, Gale M Jr: West Nile virus evades activation of interferon regulatory factor 3 through RIG-I-dependent and -independent pathways without antagonizing host defense signaling. J Virol 2006;80:2913-2923.
30. Fredericksen BL, Smith M, Katze MG, Shi PY, Gale M Jr: The host response to West Nile virus infection limits viral spread through the activation of the interferon regulatory factor 3 pathway. J Virol 2004;78:7737-7747. (Pubitemid 38915920)
31. Fredericksen BL, Keller BC, Fornek J, Katze MG, Gale M Jr: Establishment and maintenance of the innate antiviral response to West Nile virus involves both RIG-I and MDA5 signaling through IPS-1. J Virol 2008;82:609-616.
32. Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, Matsui K, Uematsu S, Jung A, Kawai T, Ishii KJ, Yamaguchi O, Otsu K, Tsujimura T, Koh CS, Reis e Sousa C, Matsuura Y, Fujita T, Akira S: Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 2006;441:101-105.
33. Balachandran S, Roberts PC, Brown LE, Truong H, Pattnaik AK, Archer DR, Barber GN: Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection. Immunity 2000;13:129-141. (Pubitemid 30953958)
34. Clemens MJ, Elia A: The double-stranded RNA-dependent protein kinase PKR: structure and function. J Interferon Cytokine Res 1997;17:503-524. (Pubitemid 27475916)
35. Balachandran S, Barber GN: PKR in innate immunity, cancer and viral oncolysis. Methods Mol Biol 2007;383:277-301.
36. Gilfoy FD, Mason PW: West Nile virus-induced interferon production is mediated by the double-stranded RNA-dependent protein kinase PKR. J Virol 2007;81:11148-11158. (Pubitemid 47536087)
37. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA: Recognition of double-stranded RNA and activation of NF-kappaB by toll-like receptor 3. Nature 2001;413:732-738. (Pubitemid 33009951)
38. Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e Sousa C: Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 2004;303:1529-1531. (Pubitemid 38314425)
39. Bowie AG, Haga IR: The role of Toll-like receptors in the host response to viruses. Mol Immunol 2005;42:859-867. (Pubitemid 40489009)
40. Vercammen E, Staal J, Beyaert R: Sensing of viral infection and activation of innate immunity by Toll-like receptor 3. Clin Microbiol Rev 2008;21:13-25. (Pubitemid 351160008)
41. Wang T, Town T, Alexopoulou L, Anderson JF, Fikrig E, Flavell RA: Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat Med 2004;10:1366-1373. (Pubitemid 40022719)
42. Daffis S, Samuel MA, Suthar MS, Gale M Jr, Diamond MS: Toll-like receptor 3 has a protective role against West Nile virus infection. J Virol 2008;82:10349-10358. (Pubitemid 352691152)
43. Kim H, Yang E, Lee J, Kim SH, Shin JS, Park JY, Choi SJ, Kim SJ, Choi IH: Double-stranded RNA mediates interferon regulatory factor 3 activation and interleukin-6 production by engaging Toll-like receptor 3 in human brain astrocytes. Immunology 2008;124:480-488. (Pubitemid 351962544)
44. Town T, Jeng D, Alexopoulou L, Tan J, Flavell RA: Microglia recognize double-stranded RNA via TLR3. J Immunol 2006;176:3804-3812. (Pubitemid 43364029)
45. Heil F, Hemmi H, Hochrein H, Ampenberger F, Kirschning C, Akira S, Lipford G, Wagner H, Bauer S: Species-specific recognition of single-stranded RNA via Toll-like receptor 7 and 8. Science 2004;303:1526-1529. (Pubitemid 38314424)
46. Triantafilou K, Vakakis E, Orthopoulos G, Ahmed MA, Schumann C, Lepper PM, Triantafilou M: TLR8 and TLR7 are involved in the host's immune response to human parechovirus 1. Eur J Immunol 2005;35:2416-2423. (Pubitemid 41179762)
47. Hornung V, Barchet W, Schlee M, Hartmann G: RNA recognition via TLR7 and TLR8. Handb Exp Pharmacol 2008:71-86.
48. Asselin-Paturel C, Brizard G, Chemin K, Boonstra A, O'Garra A, Vicari A, Trinchieri G: Type I interferon dependence of plasmacytoid dendritic cell activation and migration. J Exp Med 2005;201:1157-1167. (Pubitemid 40528442)
49. Asselin-Paturel C, Trinchieri G: Production of type I interferons: plasmacytoid dendritic cells and beyond. J Exp Med 2005;202:461-465. (Pubitemid 41186943)
50. Town T, Bai F, Wang T, Kaplan AT, Qian F, Montgomery RR, Anderson JF, Flavell RA, Fikrig E: Toll-like receptor 7 mitigates lethal West Nile encephalitis via interleukin 23-dependent immune cell infiltration and homing. Immunity 2009;30:242-253.
51. Tamura T, Yanai H, Savitsky D, Taniguchi T: The IRF family transcription factors in immunity and oncogenesis. Annu Rev Immunol 2008;26:535-584. (Pubitemid 351600385)
52. Honda K, Taniguchi T: IRFS: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol 2006;6:644-658. (Pubitemid 44298214)
53. Honda K, Yanai H, Negishi H, Asagiri M, Sato M, Mizutani T, Shimada N, Ohba Y, Takaoka A, Yoshida N, Taniguchi T: IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 2005;434:772-777. (Pubitemid 44739521)
54. Sato M, Suemori H, Hata N, Asagiri M, Ogasawara K, Nakao K, Nakaya T, Katsuki M, Noguchi S, Tanaka N, Taniguchi T: Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity 2000;13:539-548. (Pubitemid 30951877)
55. Daffis S, Samuel MA, Keller BC, Gale M Jr, Diamond MS: Cell-specific IRF-3 responses protect against West Nile virus infection by interferon-dependent and -independent mechanisms. PLoS pathogens 2007;3:e106. (Pubitemid 47203996)
56. Daffis S, Samuel MA, Suthar MS, Keller BC, Gale M Jr, Diamond MS: Interferon regulatory factor IRF-7 induces the antiviral alpha interferon response and protects against lethal West Nile virus infection. J Virol 2008;82:8465-8475.
57. Bourne N, Scholle F, Silva MC, Rossi SL, Dewsbury N, Judy B, De Aguiar JB, Leon MA, Estes DM, Fayzulin R, Mason PW: Early production of type I interferon during West Nile virus infection: role for lymphoid tissues in IRF3-independent interferon production. J Virol 2007;81:9100-9108. (Pubitemid 47311453)
58. Grandvaux N, Servant MJ, tenOever B, Sen GC, Balachandran S, Barber GN, Lin R, Hiscott J: Transcriptional profiling of interferon regulatory factor 3 target genes: Direct involvement in the regulation of interferonstimulated genes. J Virol 2002;76:5532-5539.
59. Matsuyama T, Kimura T, Kitagawa M, Pfeffer K, Kawakami T, Watanabe N, Kundig TM, Amakawa R, Kishihara K, Wakeham A, et al: Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development. Cell 1993;75:83-97. (Pubitemid 23306023)
60. Negishi H, Fujita Y, Yanai H, Sakaguchi S, Ouyang X, Shinohara M, Takayanagi H, Ohba Y, Taniguchi T, Honda K: Evidence for licensing of IFN-gamma-induced IFN regulatory factor 1 transcription factor by myd88 in Toll-like receptor-dependent gene induction program. Proc Natl Acad Sci USA 2006;103:15136-15141. (Pubitemid 44583177)
61. Schmitz F, Heit A, Guggemoos S, Krug A, Mages J, Schiemann M, Adler H, Drexler I, Haas T, Lang R, Wagner H: Interferon-regulatory-factor 1 controls Toll-like receptor 9-mediated IFN-beta production in myeloid dendritic cells. Eur J Immunol 2007;37:315-327. (Pubitemid 46915571)
62. Paun A, Reinert JT, Jiang Z, Medin C, Balkhi MY, Fitzgerald KA, Pitha PM: Functional characterization of murine interferon regulatory factor 5 (IRF-5) and its role in the innate antiviral response. J Biol Chem 2008;283:14295-14308.
63. Richez C, Yasuda K, Watkins AA, Akira S, Lafyatis R, van Seventer JM, Rifkin IR: TLR4 ligands induce IFN-alpha production by mouse conventional dendritic cells and human monocytes after IFN-beta priming. J Immunol 2009;182:820-828.
64. Marovich M, Grouard-Vogel G, Louder M, Eller M, Sun W, Wu SJ, Putvatana R, Murphy G, Tassaneetrithep B, Burgess T, Birx D, Hayes C, Schlesinger-Frankel S, Mascola J: Human dendritic cells as targets of dengue virus infection. J Investig Dermatol Symp Proc 2001;6:219-224. (Pubitemid 33758578)
65. Davis CW, Nguyen HY, Hanna SL, Sanchez MD, Doms RW, Pierson TC: West Nile virus discriminates between DC-sign and DC-signR for cellular attachment and infection. J Virol 2006;80:1290-1301.
66. Martina BE, Koraka P, van den Doel P, Rimmelzwaan GF, Haagmans BL, Osterhaus AD: DC-sign enhances infection of cells with glycosylated West Nile virus in vitro and virus replication in human dendritic cells induces production of IFN-alpha and TNF-alpha. Virus Res 2008;135:64-71.
67. Silva MC, Guerrero-Plata A, Gilfoy FD, Garofalo RP, Mason PW: Differential activation of human monocyte-derived and plasmacytoid dendritic cells by West Nile virus generated in different host cells. J Virol 2007;81:13640-13648. (Pubitemid 350247857)
68. Fitzgerald-Bocarsly P, Feng D: The role of type I interferon production by dendritic cells in host defense. Biochimie 2007;89:843-855. (Pubitemid 47001647)
69. Delhaye S, Paul S, Blakqori G, Minet M, Weber F, Staeheli P, Michiels T: Neurons produce type I interferon during viral encephalitis. Proc Natl Acad Sci USA 2006;103:7835-7840. (Pubitemid 43752867)
70. Klein RS, Lin E, Zhang B, Luster AD, Tollett J, Samuel MA, Engle M, Diamond MS: Neuronal cxcl10 directs CD8+ T-cell recruitment and control of West Nile virus encephalitis. J Virol 2005;79:11457-11466. (Pubitemid 41170686)
71. Kalil AC, Devetten MP, Singh S, Lesiak B, Poage DP, Bargenquast K, Fayad P, Freifeld AG: Use of interferon-alpha in patients with west nile encephalitis: report of 2 cases. Clin Infect Dis 2005;40:764-766. (Pubitemid 40381356)
72. Liu WJ, Chen HB, Wang XJ, Huang H, Khromykh AA: Analysis of adaptive mutations in kunjin virus replicon RNA reveals a novel role for the flavivirus nonstructural protein NS2A in inhibition of beta interferon promoter-driven transcription. J Virol 2004;78:12225-12235. (Pubitemid 39458742)
73. Liu WJ, Wang XJ, Clark DC, Lobigs M, Hall RA, Khromykh AA: A single amino acid substitution in the West Nile virus nonstructural protein NS2A disables its ability to inhibit alpha/beta interferon induction and attenuates virus virulence in mice. J Virol 2006;80:2396-2404. (Pubitemid 43271545)
74. Scholle F, Mason PW: West Nile virus replication interferes with both poly(i:C)-induced interferon gene transcription and response to interferon treatment. Virology 2005;342:77-87. (Pubitemid 41531987)
75. Wilson JR, de Sessions PF, Leon MA, Scholle F: West Nile virus nonstructural protein 1 inhibits TLR3 signal transduction. J Virol 2008;82:8262-8271.
76. Arjona A, Ledizet M, Anthony K, Bonafe N, Modis Y, Town T, Fikrig E: West Nile virus envelope protein inhibits dsRNA-induced innate immune responses. J Immunol 2007;179:8403-8409.
77. Kong KF, Wang X, Anderson JF, Fikrig E, Montgomery RR: West Nile virus attenuates activation of primary human macrophages. Viral Immunol 2008;21:78-82.
78. Miller JL, deWet BJ, Martinez-Pomares L, Radcliffe CM, Dwek RA, Rudd PM, Gordon S: The mannose receptor mediates dengue virus infection of macrophages. PLoS pathogens 2008;4:e17.
79. Chen ST, Lin YL, Huang MT, Wu MF, Cheng SC, Lei HY, Lee CK, Chiou TW, Wong CH, Hsieh SL: Clec5a is critical for dengue-virus-induced lethal disease. Nature 2008;453:672-676.
80. Guo JT, Hayashi J, Seeger C: West Nile virus inhibits the signal transduction pathway of alpha interferon. J Virol 2005;79:1343-1350. (Pubitemid 40459081)
81. Evans JD, Seeger C: Differential effects of mutations in NS4B on West Nile virus replication and inhibition of interferon signaling. J Virol 2007;81:11809-11816.
82. Mackenzie JM, Khromykh AA, Parton RG: Cholesterol manipulation by West Nile virus perturbs the cellular immune response. Cell Host Microbe 2007;2:229-239.